Abstract
The authors describe a diabetic patient on spironolactone who, following a minor surgical procedure, developed ketoacidosis and life-threatening hyperkalaemia.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- GUNDERSEN K., BRADLEY R. F., MARBLE A. Serum phosphorus and potassium levels after intravenous administration of glucose; their use as diagnostic acids in diabetic and nondiabetic subjects with and without liver disease. N Engl J Med. 1954 Apr 1;250(13):547–554. doi: 10.1056/NEJM195404012501302. [DOI] [PubMed] [Google Scholar]
- Herman E., Rado J. Fatal hyperkalemic paralysis associated with spironalactone. Observation on a patient with severe renal disease and refractory edema. Arch Neurol. 1966 Jul;15(1):74–77. doi: 10.1001/archneur.1966.00470130078008. [DOI] [PubMed] [Google Scholar]
- Karim A., Zagarella J., Hribar J., Dooley M. Spironolactone. I. Disposition and metabolism. Clin Pharmacol Ther. 1976 Feb;19(2):158–169. doi: 10.1002/cpt1976192158. [DOI] [PubMed] [Google Scholar]
- McNay J. L., Oran E. Possible predisposition of diabetic patients to hyperkalemia following administration of potassium-retaining diuretic, amiloride (MK 870). Metabolism. 1970 Jan;19(1):58–70. doi: 10.1016/0026-0495(70)90118-6. [DOI] [PubMed] [Google Scholar]